Home > Cashflow Statement > GENPHARMASEC

GENPHARMASEC
Cashflow Statement

GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023
Profit Before Tax₹0.25 Cr₹0.28 Cr
Adjustment ₹0.39 Cr₹0.16 Cr
Changes In working Capital ₹-3.54 Cr₹-3.77 Cr
Cash Flow after changes in Working Capital ₹-2.91 Cr₹-3.32 Cr
Cash Flow from Operating Activities ₹-2.95 Cr₹-3.06 Cr
Cash Flow from Investing Activities ₹-28 Cr₹0.36 Cr
Cash Flow from Financing Activities ₹48 Cr₹3.08 Cr
Net Cash Inflow / Outflow ₹17 Cr₹0.39 Cr
Opening Cash & Cash Equivalents ₹1.99 Cr₹1.61 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger --
Cash & Cash Equivalent of Subsidiaries under liquidations --
Translation adjustment on reserves / op cash balalces frgn subsidiaries --
Effect of Foreign Exchange Fluctuations --
Closing Cash & Cash Equivalent ₹19 Cr₹1.99 Cr

Compare Cashflow Statement of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹110.7 Cr -1.5% -3.4% -15.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,818.9 Cr -0.8% 3.3% 43.7% Stock Analytics
KIRI INDUSTRIES ₹3,160.3 Cr -2.3% -3.1% 65.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,995.6 Cr -0.5% -4.1% -7.9% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,187.0 Cr -2.5% 18.4% 64% Stock Analytics
BODAL CHEMICALS ₹938.8 Cr -3% 1.1% 0.2% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-1.5%

-3.4%

-15.1%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses